MTNB (STOCKS)

    Matinas BioPharma Holdings, Inc.

    $0.239100
    -0.000900 (-0.37%)
    Prev close: $0.240000
    Company Information
    Exchange
    XASE
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Jerome D. Jabbour
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $3.33M
    Employees
    34
    P/E (TTM)
    -0.12
    P/B (TTM)
    0.51
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues $0.00
    Costs And Expenses $6.95M
    Depreciation and Amortization $17.00K
    Operating Income/Loss -$6.95M
    Income/Loss From Continuing Operations After Tax -$10.62M
    Income/Loss From Continuing Operations Before Tax -$10.34M
    Net Income/Loss -$10.61M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$10.61M
    Net Income/Loss Available To Common Stockholders, Basic -$11.23M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $618.00K
    Preferred Stock Dividends And Other Adjustments $618.00K
    Basic Earnings Per Share -$1.99
    Diluted Earnings Per Share -$1.99
    Basic Average Shares 17,198,590
    Diluted Average Shares 17,198,590
    Assets $5.87M
    Current Assets $2.82M
    Noncurrent Assets $3.06M
    Fixed Assets $138.00K
    Intangible Assets $2.26M
    Other Non-current Assets $661.00K
    Liabilities $2.85M
    Current Liabilities $2.13M
    Accounts Payable $712.00K
    Other Current Liabilities $1.41M
    Noncurrent Liabilities $726.00K
    Equity $3.02M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $3.02M
    Liabilities And Equity $5.87M
    Net Cash Flow From Operating Activities -$6.61M
    Net Cash Flow From Operating Activities, Continuing -$6.61M
    Net Cash Flow -$2.88M
    Net Cash Flow, Continuing -$2.88M
    Comprehensive Income/Loss -$10.61M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$10.61M
    Other Comprehensive Income/Loss -$8.69M